PureTech Health Plc (LON:PRTC) Buy Rating Maintained by Peel Hunt; With GBX 313.00 Target; Changyoucom Limited American Deposit (CYOU) Sellers Increased By 19.64% Their Shorts

Equities researchers at Peel Hunt have GBX 313.00 target on PureTech Health Plc (LON:PRTC). Peel Hunt’s target indicates a potential upside of 74.37% from the company’s last stock price. The rating was released in a research report on Friday, 26 January.

Changyoucom Limited American Deposit (NASDAQ:CYOU) had an increase of 19.64% in short interest. CYOU’s SI was 2.10 million shares in January as released by FINRA. Its up 19.64% from 1.76 million shares previously. With 255,000 avg volume, 8 days are for Changyoucom Limited American Deposit (NASDAQ:CYOU)’s short sellers to cover CYOU’s short positions. The SI to Changyoucom Limited American Deposit’s float is 13.9%. The stock decreased 3.17% or $1.08 during the last trading session, reaching $32.99. About 182,424 shares traded. Changyou.com Limited (NASDAQ:CYOU) has risen 121.43% since January 26, 2017 and is uptrending. It has outperformed by 104.73% the S&P500.

Changyou.com Limited develops and operates online games in the PeopleÂ’s Republic of China. The company has market cap of $1.68 billion. The firm operates through Online Game, Platform Channel, and Others divisions. It has a 15.32 P/E ratio. It develops, operates, and licenses online games, including interactive online games that are accessed and played simultaneously by various game players through personal computers; and mobile games played on mobile devices.

Among 6 analysts covering Changyou.com (NASDAQ:CYOU), 2 have Buy rating, 2 Sell and 2 Hold. Therefore 33% are positive. Changyou.com has $31.70 highest and $17 lowest target. $21.68’s average target is -34.28% below currents $32.99 stock price. Changyou.com had 12 analyst reports since October 8, 2015 according to SRatingsIntel. Macquarie Research upgraded the shares of CYOU in report on Tuesday, February 21 to “Neutral” rating. Goldman Sachs downgraded the stock to “Sell” rating in Monday, November 30 report. The firm has “Equal-Weight” rating given on Friday, February 24 by Morgan Stanley. The company was initiated on Friday, September 9 by Deutsche Bank. Macquarie Research maintained Changyou.com Limited (NASDAQ:CYOU) rating on Monday, October 19. Macquarie Research has “Neutral” rating and $20 target. The rating was upgraded by Credit Suisse to “Outperform” on Wednesday, February 22. As per Tuesday, July 26, the company rating was downgraded by Macquarie Research. As per Monday, October 30, the company rating was upgraded by Deutsche Bank. Credit Suisse downgraded Changyou.com Limited (NASDAQ:CYOU) rating on Thursday, February 4. Credit Suisse has “Neutral” rating and $17 target.

The stock increased 0.28% or GBX 0.5 during the last trading session, reaching GBX 180. About 30,193 shares traded. PureTech Health plc (LON:PRTC) has 0.00% since January 26, 2017 and is . It has underperformed by 16.70% the S&P500.

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company has market cap of 427.37 million GBP. The firm is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It currently has negative earnings. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia.

Among 5 analysts covering Puretech Health Plc (LON:PRTC), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Puretech Health Plc has GBX 313 highest and GBX 194 lowest target. GBX 257.60’s average target is 43.11% above currents GBX 180 stock price. Puretech Health Plc had 89 analyst reports since July 30, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, September 25 by Liberum Capital. The stock has “Buy” rating by Liberum Capital on Friday, March 24. On Tuesday, August 16 the stock rating was maintained by Peel Hunt with “Buy”. Liberum Capital maintained PureTech Health plc (LON:PRTC) rating on Thursday, October 29. Liberum Capital has “Buy” rating and GBX 194 target. The rating was maintained by Liberum Capital with “Buy” on Thursday, April 6. As per Thursday, December 15, the company rating was maintained by Peel Hunt. As per Monday, November 9, the company rating was maintained by Jefferies. Liberum Capital maintained the stock with “Buy” rating in Wednesday, August 30 report. N+1 Singer maintained the stock with “Buy” rating in Monday, December 4 report. Jefferies maintained it with “Buy” rating and GBX 235 target in Tuesday, August 25 report.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: